Is BHRT safe? What do doctors say about bioidentical hormones?

Short answer

• “Bioidentical hormones” means hormones chemically identical to the ones your body makes. Some of those (estradiol, micronized progesterone) are available as FDA‑approved prescription products and are generally considered safe and effective when used appropriately.
• Doctors and major medical organizations generally support evidence‑based hormone therapy for appropriate patients, but warn that custom‑compounded “BHRT” marketed as safer or more natural is unproven and carries extra risk because it isn’t regulated or consistent.

What doctors and major organizations say

• North American Menopause Society (NAMS), the Endocrine Society, ACOG and the FDA: hormone therapy can be a good, effective treatment for menopausal symptoms and some other hormone deficiencies when benefits outweigh risks. They recommend using FDA‑approved products when possible, individualized dosing, and regular follow‑up.
• Many clinicians oppose routine use of compounded, custom BHRT formulations (or use of saliva hormone tests) because these products aren’t FDA‑regulated, can have variable potency/contamination, and there’s little high‑quality evidence that they’re safer or better than approved therapies. Some integrative physicians do use compounded BHRT and report good symptom control, but that approach is controversial.

Evidence and safety points (concise)

• For menopausal hot flashes, vaginal dryness and some quality‑of‑life issues, estrogen (often combined with progesterone if you still have a uterus) is effective.
• Risks depend on age, timing and preparation: starting estrogen near menopause in healthy women has a different risk profile than starting late. Oral estrogens have greater effect on liver proteins and clotting factors (higher VTE risk) versus transdermal estrogens, which appear to have lower VTE risk.
• Combined estrogen + some synthetic progestins were associated with a small increased breast‑cancer signal in WHI; micronized progesterone may have a more favorable safety profile than some synthetic progestins.
• Possible adverse effects: blood clots, stroke, changes in cholesterol, possible small changes in breast cancer risk depending on formulation and duration, and androgenic effects if testosterone is used (acne, hair growth).
• Testosterone for women (for low libido) is an area with limited evidence and no broadly approved female testosterone product in many countries; it is sometimes prescribed off‑label or via compounding.

Practical recommendations (what to do)

• See a board‑certified OB‑GYN, endocrinologist, or menopause specialist for individualized risk/benefit counseling. They will ask about age, time since menopause, personal and family history, and cardiovascular and breast cancer risk factors.
• Prefer FDA‑approved products and formulations with published safety/efficacy data. Avoid reliance on saliva hormone tests; doctors usually prefer validated blood tests and clinical symptom assessment.
• Start with the lowest effective dose and reassess symptoms and risks regularly.

Specific products doctors commonly use (examples and why)

• Transdermal estradiol patches or gels (examples: Vivelle‑Dot/estradiol patch, Climara, EstroGel or generic transdermal estradiol): transdermal delivery avoids first‑pass liver effects and is associated with lower VTE risk than oral estrogen for many women.
• Oral estradiol tablets (example: Estrace): effective for systemic symptoms; clinicians choose oral vs transdermal based on individual risk profile.
• Micronized progesterone (example: Prometrium): an FDA‑approved, bioidentical progesterone product many doctors prefer over synthetic progestins because some data suggest a more favorable impact on breast and clotting risk.
• Vaginal estradiol (examples: Vagifem, Estrace cream, Estring): for primarily local vaginal symptoms, low‑dose vaginal therapy gives symptom relief with lower systemic exposure.

If considering compounded BHRT

• If you and your clinician decide you need a compounded product (sometimes used when a specific dose or delivery form isn’t commercially available), use a reputable, accredited compounding pharmacy (look for PCAB accreditation) and understand that compounded preparations are not FDA‑approved and may have variable potency. Ask your clinician why a compounded product is necessary and what monitoring will be done.

Bottom line

• Bioidentical hormones can be safe and effective when they’re prescription, FDA‑approved products used under medical supervision and tailored to your risks and goals. “Custom‑compounded” BHRT is more controversial and less well regulated; most mainstream medical groups recommend FDA‑approved options first. Discuss options, risks and monitoring with a menopause‑experienced clinician.

If you want, tell me your age, menopause status and main symptoms and I can outline specific options and monitoring steps you can discuss with your doctor.